QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
A warm welcome to our new interns!🟢
We are delighted to welcome Honey Saini, Khushi Lamba, Priyank Gupta and Shubhdeep Singh, who joined Quantify Research last week as interns in our Evidence Review and Synthesis team.
It is always exciting to welcome new colleagues, fresh perspectives and new ideas to the team. We look forward to learning from one another and working together.
We are glad to have you on board! 👏
[…]
7 days to go until ISPOR Europe 2026!
As we prepare for Vienna, we’re looking forward to the discussions that will help shape the future of real-world evidence (RWE).
Quantify Research’s CEO and athagoras Group Head of RWE, Kirk Geale, PhD, Co-Chair of the ISPOR RWE Special Interest Group (SIG), will be co-moderating the ISPOR RWE SIG Open Meeting.
The meeting brings together RWE professionals to exchange perspectives on some of the field’s […]
Five posters. Five important research questions. The power of Nordic real-world data.
At ISPOR Europe 2026, Quantify Research colleagues will present collaborative research demonstrating how Nordic national registers can inform healthcare decision-making.
The research spans treatment patterns, treatment persistence, and the economic and societal burden of disease across several therapeutic areas.
📊 Here‘s where you can find our research in Vienna:
📅 Monday 9 November | 🕥 10:30 – […]
📊EQ-5D-5L: Does the choice of value set influence cost-effectiveness conclusions
How health-related quality of life is valued can have important implications for QALY calculations, cost-effectiveness assessments, and ultimately, reimbursement decisions.
A new report from the Health Economics and Policy research group at Karolinska Institutet, commissioned by the Tandvårds- och läkemedelsförmånsverket, TLV examines this question.
Building on previous research, the report systematically compares newly developed Swedish, Nordic, and UK EQ-5D-5L […]
